Femasys inc. receives u.s. fda clearance to market femchec®, an innovative diagnostic solution for fallopian tube check

In addition to 510(k) clearance, femchec, a contrast generating product, is an integral part of the confirmation test following administration of fembloc non-surgical permanent birth control, currently in late-stage pivotal trial in addition to 510(k) clearance, femchec, a contrast generating product, is an integral part of the confirmation test following administration of fembloc non-surgical permanent birth control, currently in late-stage pivotal trial
FEMY Ratings Summary
FEMY Quant Ranking